동물용 백신 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 동물 종류별, 투여 경로별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Route Of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1878871
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 동물용 백신 시장은 2024년에 76억 8,000만 달러로 평가되었으며, 2030년까지 CAGR 8.69%로 성장하여 126억 6,000만 달러에 달할 것으로 예측됩니다.
세계 동물용 백신 시장은 가축과 반려동물을 포함한 다양한 동물 종에서 감염성 질환에 대한 면역을 자극하도록 설계된 생물학적 제제로 구성되어 있습니다. 이러한 백신은 인수공통전염병의 전파를 통제함으로써 질병 예방, 사망률 감소, 공중보건 보호에 매우 중요합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
76억 8,000만 달러
시장 규모 : 2030년
126억 6,000만 달러
CAGR : 2025-2030년
8.69%
가장 빠르게 성장하는 부문
축산
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 동물용 백신 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(약독화 생백신, 불활화 백신, 아단위 백신, DNA 백신, 재조합 백신)
동물 종류별(축산동물, 반려동물, 기타)
투여 경로별(피하 투여, 근육내 투여, 비강내 투여)
유통 채널별(동물 병원, 동물 진료소, 약국·드럭스토어, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 동물용 백신 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 동물용 백신 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 동물용 백신 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 동물용 백신 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 동물용 백신 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 동물용 백신 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Biogenesis Bago SA
Indian Immunologicals Ltd.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Neogen Corporation
Intas Pharmaceuticals Ltd.
Ouro Fino Saude Animal
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Animal Vaccine Market , valued at USD 7.68 Billion in 2024, is projected to experience a CAGR of 8.69% to reach USD 12.66 Billion by 2030. The global animal vaccine market comprises biological preparations designed to stimulate immunity against infectious diseases across various animal species, including livestock and companion animals. These vaccines are crucial for disease prevention, mortality reduction, and public health protection by controlling zoonotic transmission.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.68 Billion
Market Size 2030
USD 12.66 Billion
CAGR 2025-2030
8.69%
Fastest Growing Segment
Livestock
Largest Market
North America
Key Market Drivers
The global animal vaccine market is primarily influenced by the rising incidence of zoonotic diseases and the increasing global demand for animal-derived food products. Zoonotic diseases, transmissible between animals and humans, necessitate extensive animal vaccination to mitigate public health risks. For example, according to Forbes, in December 2024, a major mpox epidemic in the Democratic Republic of the Congo and neighboring countries recorded over 16,000 confirmed cases, prompting a public health emergency declaration from the World Health Organization. This underscores the critical role of veterinary vaccines in preventing disease transmission at the human-animal interface.
Key Market Challenges
The substantial cost associated with vaccine research, development, and stringent regulatory approval processes represents a significant impediment to the expansion of the Global Animal Vaccine Market. These extensive financial requirements elevate production expenses, directly impacting vaccine accessibility and affordability, particularly within developing economies where resources are often constrained. The prolonged timelines and complex regulatory pathways demand considerable capital investment, which restricts the number of new vaccines brought to market and limits the capacity for existing ones to be widely distributed at competitive prices.
Key Market Trends
The Global Animal Vaccine Market is significantly influenced by the rapid advancements in next-generation vaccine technologies. This trend encompasses the development of more sophisticated solutions such as recombinant, subunit, and mRNA-based vaccines, moving beyond traditional attenuated or inactivated forms. These innovative vaccines offer enhanced efficacy, improved safety profiles, and often enable faster development cycles and more targeted protection against specific pathogens. According to the World Health Organization's (WHO) 2024 Global Vaccine Market Report, in 2023, 88 vaccine products were sold across 207 countries by 116 manufacturers, underscoring the broad market where technological advancements are being applied.
Key Market Players
Zoetis Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Biogenesis Bago SA
Indian Immunologicals Ltd.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Neogen Corporation
Intas Pharmaceuticals Ltd.
Ouro Fino Saude Animal
Report Scope:
In this report, the Global Animal Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Animal Vaccine Market , By Product:
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
Animal Vaccine Market , By Animal Type:
Livestock
Companion
Others
Animal Vaccine Market , By Route Of Administration:
Subcutaneous
Intramuscular
Intranasal
Animal Vaccine Market , By Distribution Channel:
Veterinary Hospitals
Veterinary Clinics
Pharmacies & Drug Stores
Others
Animal Vaccine Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Animal Vaccine Market .
Available Customizations:
Global Animal Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Animal Vaccine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
5.2.2. By Animal Type (Livestock, Companion, Others)
5.2.3. By Route Of Administration (Subcutaneous, Intramuscular, Intranasal)
5.2.4. By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Animal Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Route Of Administration
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Vaccine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Animal Type
6.3.1.2.3. By Route Of Administration
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Animal Vaccine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Animal Type
6.3.2.2.3. By Route Of Administration
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Animal Vaccine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Animal Type
6.3.3.2.3. By Route Of Administration
6.3.3.2.4. By Distribution Channel
7. Europe Animal Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Route Of Administration
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Animal Type
7.3.1.2.3. By Route Of Administration
7.3.1.2.4. By Distribution Channel
7.3.2. France Animal Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Animal Type
7.3.2.2.3. By Route Of Administration
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Animal Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Animal Type
7.3.3.2.3. By Route Of Administration
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Animal Vaccine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Animal Type
7.3.4.2.3. By Route Of Administration
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Animal Vaccine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Animal Type
7.3.5.2.3. By Route Of Administration
7.3.5.2.4. By Distribution Channel
8. Asia Pacific Animal Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Animal Type
8.2.3. By Route Of Administration
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Animal Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Animal Type
8.3.1.2.3. By Route Of Administration
8.3.1.2.4. By Distribution Channel
8.3.2. India Animal Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Animal Type
8.3.2.2.3. By Route Of Administration
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Animal Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Animal Type
8.3.3.2.3. By Route Of Administration
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Animal Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Animal Type
8.3.4.2.3. By Route Of Administration
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Animal Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Animal Type
8.3.5.2.3. By Route Of Administration
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Animal Vaccine Market Outlook
